Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
NCT02685852
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Hyperinsulinemic Hypoglycemia
Interventions
DRUG:
Exenatide
DRUG:
Acarbose
DRUG:
Exenatide Placebo
DRUG:
Acarbose Placebo
Sponsor
University of Minnesota